Heterofuctionalisation of C=C and C-H bonds

Enantioselective aza-Michael reactions

Dicationic (BINAP)palladium(II) complex induced high enantioselectiviies in the addition of primary (and secondary) aromatic amines to N-alkenoyl oxazolidinones (up to 93% ee), imides (89% ee), and carbamates (>99 % ee).
The mechanism of these reactions was examined fusing a combination of techniques, including X-ray crystallography, mass spectrometry, NMR, UV/Vis spectroscopy, and kinetic studies. The study culminated in the design of a new reaction protocol, which was subsequently applied to the synthesis of torcetrapib, a drug being developed to treat hypercholesterolemia.

Mobirise

Enantioselective alpha-hydroxylation of 1,3-diketones

Concepts developed in the above were extended to the heterofunctionalisation of the acidic C-H present in 1,3-ketoesters. Using dicationic Pd(II) as a catalyst, very high ee's (up to 98%) can be achieve in the alpha-hydroxylation of 1,3-ketoesters. To this date, these records remained unsurpassed.
The stereoselectivity was rationalized by transition state modeling, which revealed a number of cooperative weak interactions between oxidant, ligand and counterion, together with C-H/pit interactions that cumulatively account for the unusual stereoselectivity. 

Mobirise

Copper Catalysis

The use of cheap Cu(II) catalysts for N-H and O-H addition to C=C bonds. We have developed a number of methodologies that can be used for the synthesis of biologically interesting heterocyclic molecules.

Mobirise

Silver Catalysis

Silver catalysis is overlooked by the synthetic community, even though it is very often deployed as a co-catalyst (to generate cationic species, for example). We have found that silver catalysts can be used to effect the intramolecular N-H and O-H addition to C=C bonds, including the first enantioselective examples.
Likewise, silver-NHC complexes are often used to prepare other catalysts, but their catalytic activity is not demonstrated. We have shown that their reactivity can be 'tuned' by the ligand structure.

Mobirise

No Code Website Builder